Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-02-28

Clinical Trial Update: Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil [Phase 3]

View source ↗

Summary

Phase 3 trial of fixed-dose combination etoricoxib + cyclobenzaprine for pain relief after third molar extraction was withdrawn in Brazil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • etoricoxib + cyclobenzaprine fixed-dose combination

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Third Molar Extraction | Phase 3 | Status: WITHDRAWN